CLOs on the Move

Arthrex

www.arthrex.com

 
Arthrex, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Arthrex, Inc. is based in Naples, FL. You can find more information on Arthrex, Inc. at www.arthrex.com
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details
Enock Chibende
Director, Global Compliance Assurance Profile
Jason Vendel
Regional Compliance Officer for North America and Global Privacy Profile
Courtney Smith
Director, Regulatory Affairs Profile
Trevor Arnold
Chief IP Counsel Profile

Similar Companies

Canadian Association of Gastroenterology

Canadian Association of Gastroenterology is a Oakville, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Georgia Atkison Snf

Georgia Atkison Snf is a El Monte, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lumeris

Lumeris is a value-based care managed services operator for health systems and providers seeking extraordinary clinical and financial outcomes. Lumeris aligns providers and payers across populations with technologies, processes, behaviors and information to achieve high-quality, cost-effective care with satisfied consumers — and engaged physicians. Lumeris with Essence Healthcare, its inaugural client with more than 60,000 Medicare members in Missouri and Illinois, has averaged a CMS rating of 4.5 Stars for the last ten years and produced the highest consumer and physician satisfaction scores in the industry along with significantly better clinical outcomes and lower costs.

RX Staffing and Home Care

RX Staffing & Home Care is a Sacramento, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Plasmatech Biopharmaceuticals

Abeona Therapeutics is focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. Abeona’s lead program is an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome (MPS IIIA and IIIB) in collaboration with patient advocate groups, researchers and clinicians. Clinical trials for Sanfilippo types A and B are anticipated to begin in 2015.